| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3876755 | The Journal of Urology | 2008 | 5 Pages |
Abstract
In our study neither serum nor urinary myeloid related protein-14 proved suitable to distinguish prostate cancer cases from controls. Overall myeloid related protein-14 performed much worse than prostate specific antigen and it does not seem useful to reduce false-positive findings of prostate specific antigen in the controversial range of 4 to 10 ng/ml.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Heiko Müller, Ulrike Haug, Dietrich Rothenbacher, Christa Stegmaier, Hermann Brenner,